First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Clinical trial NCT01215136 · TERMINATED
Trial details
- NCT number
- NCT01215136
- Sponsor
- Matthew Galsky
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2017-04-24
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.